Trial Profile
A Study to Evaluate the Contemporary Use of Ticagrelor in Coronary Artery Disease (CAD) in Patients Who Underwent Percutaneous Coronary Interventions (PCI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 29 Dec 2015 New trial record